Levemir News
Most Popular Levemir Story
Mixed data for Novo's diabetes drug
Novo Nordisk's long-lasting insulin drug Levemir turned in mixed results in a Phase III trial. Bad news first: Patients taking the drug were less likely to achieve blood sugar control than those... Read more...
Latest Headlines
- September 21, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
